VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 43 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
| Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
| ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
| BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
| HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
| Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
| Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |